Role of Vitamin K in coagulation

Last updated: July 09, 2022

Role of Vitamin K in coagulation

Spring 21 Unit 7

Spring 21 Unit 7

Brain herniation
Diabetic nephropathy
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Myocardial infarction
ECG cardiac infarction and ischemia
DALY and QALY
Atherosclerosis and arteriosclerosis: Pathology review
Insulins
Miscellaneous hypoglycemics
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes insipidus
Diabetes mellitus: Clinical
Diabetic retinopathy
Urinary incontinence
Plasma anion gap
Hypoglycemics: Insulin secretagogues
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Thrombolytics
Antiplatelet medications
Ischemic stroke
Dizziness and vertigo: Clinical
Stroke: Clinical
Cerebellum
Vertigo
Zollinger-Ellison syndrome
MEN syndromes: Clinical
Multiple endocrine neoplasia: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Acid reducing medications
Pancreatic neuroendocrine neoplasms
Peptic ulcer
Peptic ulcers and stomach cancer: Clinical
Ulcerative colitis
Helicobacter pylori
Coronary artery disease: Pathology review
Heart blocks: Pathology review
Peripheral artery disease: Pathology review
Ventricular fibrillation
Wolff-Parkinson-White syndrome
Inflammation
Lupus nephritis
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Raynaud phenomenon
Sjogren syndrome: Clinical
Sjogren syndrome
Scleroderma
Limited systemic sclerosis (CREST syndrome)
Vitamin D
Parathyroid conditions and calcium imbalance: Clinical
Class II antiarrhythmics: Beta blockers
Class I antiarrhythmics: Sodium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Long QT syndrome and Torsade de pointes
Calcium channel blockers
Horner syndrome
Cervix and vagina histology
Urinary incontinence: Pathology review
Rubella virus
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Sjogren syndrome: Clinical
Osteoarthritis
Seronegative arthritis: Clinical
Joint pain: Clinical
Systemic lupus erythematosus (SLE): Pathology review
Cerebral circulation

Transcript

Watch video only

Vitamin K helps to regulate the process of blood coagulation by assisting in the conversion of certain coagulation factors into their mature forms. Without vitamin K, our bodies would be unable to control clot formation. Imagine being unable to form blood clots effectively--that would mean that we would lose all of our blood volume from something as simple as a pinprick! To prevent this extreme scenario - vitamin K must be ingested, metabolized, and utilized to create mature coagulation factors.

Now, to understand the regulation of clot formation, we first need to talk briefly about hemostasis, in which hemo refers to the blood, and stasis means to halt or stop. Hemostasis is divided into two phases: primary and secondary hemostasis. Primary hemostasis involves the formation of a platelet plug around the site of an injured blood vessel, and secondary hemostasis reinforces the platelet plug with the creation of a protein mesh called fibrin. To get to fibrin, a set of coagulation factors, each of which are enzymes, need to be activated. These enzymes are activated via a process called proteolysis- which is where a portion of the protein is clipped off. In total, there are twelve coagulation factors numbered factors I-XIII, there’s no factor VI. Most of these factors are produced by liver cells, and it turns out that producing coagulation factors II, VII, IX, and X requires an enzyme that uses vitamin K.

Vitamin K is found in abundance in green leafy foods—things like spinach, kale, and chard which all have high concentrations of vitamin K. It’s a fat-soluble vitamin, along with vitamins A, D, and E, meaning that it can be stored in fat cells instead of being excreted by the kidneys. Vitamin K is also synthesized by bacteria in our gastrointestinal tract as a byproduct of their metabolism, which further contributes to overall intake.

Key Takeaways

Vitamin K plays a crucial role in blood coagulation, which is the process by which the body forms clots to stop bleeding. Vitamin K acts as a cofactor for a group of proteins known as the vitamin K-dependent clotting factors (II, VII, IX, and X ), which are involved in the activation of blood-clotting proteins. To be useful, vitamin K undergoes a series of oxidation and reduction reactions called the vitamin K cycle.

Vitamin K deficiency can result in impaired blood clotting, leading to spontaneous bleeding or excessive bleeding from cuts or injuries. Newborn infants are at particular risk because they have limited stores of vitamin K, and are often not able to produce enough of the vitamin on their own. This is why they are typically given a single injection of vitamin K shortly after birth.

Sources

  1. "Medical Physiology" Elsevier (2016)
  2. "Physiology" Elsevier (2017)
  3. "Human Anatomy & Physiology" Pearson (2018)
  4. "Principles of Anatomy and Physiology" Wiley (2014)
  5. "The role of vitamins in hemostasis" Thromb Diath Haemorrh (1975)
  6. "Vitamin K--dependent clotting factors" Semin Thromb Hemost (1977)